Mammalian transcription factors in yeast: Strangers in a familiar land

Nature Reviews Molecular Cell Biology

Volumn 3, Issue 1, 2002, Pages 41-49

  Kennedy, Brian K ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

DNA BINDING PROTEIN; REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REPORTER GENE; REVIEW; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION;

ANIMALS; DNA-BINDING PROTEINS; GENES, REPORTER; HUMANS; MODELS, GENETIC; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0036372149     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm704     Document Type: Review

References (115)

1. Brownell, J. et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acteylation to gene expression. Cell 84, 843-851 (1996).
2. Taunton, J., Hassig, C. A. & Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411 (1996).
3. Chen, D. et al. Regulation of transcription by a protein methyltransferase. Science 284, 2174-2177 (1999).
4. Strahl, B. D., Ohba, R., Cook, R. G. & Allis, C. D. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl Acad. Sci. USA 96, 14967-14972 (1999).
5. Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599 (2000).
6. Sassone-Corsi, P et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285, 886-891 (1999).
7. Thomson, S. et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 18, 4773-4793 (1999).
8. Bestor, T., Laudano, A., Mattaliano, R. & Ingram, V. Cloning and sequencing of a cDNA methyltransferase of mouse cells. The carboxy-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203, 971-983 (1988).
9. Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219-220 (1998).
10. Kawasaki, H. et al. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405, 195-200 (2000).
11. Laurent, B. C., Treich, I. & Carlson, M. The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. Genes Dev. 7, 583-591 (1993).
12. Cote, J., Quinn, J., Workman, J. L. & Peterson, C. L. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265, 53-60 (1994).
13. Kwon, H., Imbalzano, A. N., Khavari, P. A., Kingston, R. E. & Green, M. R. Nucleosome disruption and enhancement of activator binding by a human SWI/SNF complex. Nature 370, 477-481 (1994).
14. Näär, A. M., Lemon, B. D. & Tjian, R. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70, 475-501 (2001).
15. Strubin, M. & Struhl, K. Yeast and human TFIID with altered DNA-binding specificity for TATA elements. Cell 68, 721-730 (1992).
16. Keaveney, M., Berkenstam, A., Feigenbutz, M., Vriend, G. & Stunnenberg, H. G. Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells. Nature 365, 562-566 (1993).
17. Cormack, B. P., Strubin, M., Stargell, L. A. & Struhl, K. Conserved and nonconserved functions of the yeast and human TATA-binding proteins. Genes Dev. 8, 1335-1343 (1994).
18. Sweetser, D., Nonet, M. & Young, R. Prokaryotic and eukaryotic RNA polymerases have homologous core subunits. Proc. Natl Acad. Sci. USA 84, 1192-1196 (1987).
19. Dynlacht, B. D., Hoey, T. & Tjian, R. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 66, 563-576 (1991).
20. Candau, R. et al. Identification of human proteins functionally conserved with the yeast putative adaptors ADA2 and GCN5. Mol. Cell. Biol. 16, 593-602 (1996).
21. Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H. & Nakatani, Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324 (1996).
22. Khavari, P. A., Peterson, C. L., Tamkun, J. W., Mendel, D. B. & Crabtree, G. R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366, 170-174 (1993).
23. Brent, R. & Ptashne, M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell 43, 729-736 (1985).
24. Hope, I. A. & Struhl, K. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast. Cell 46, 885-894 (1986).
25. Fields, S. & Song, O. A novel genetic system to detect protein-protein interactions. Nature 340, 245-246 (1989).
26. Struhl, K. The DNA-binding domains of the jun oncoprotein and the yeast GCN4 transcriptional activator protein are functionally homologous. Cell 50, 841-846 (1987).
27. Bohmann, D. et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238, 1386-1392 (1987).
28. Kakidani, H. & Ptashne, M. GAL4 activates gene expression in mammalian cells. Cell 52, 161-167 (1988).
29. Webster, N., Jin, J. R., Green, S., Hollis, M. & Chambon, P. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52, 169-178 (1988). References 28 and 29 were the first reports to show that yeast activators can function in mammalian cells.
30. Struhl, K. The JUN oncoprotein, a vertebrate transcription factor, activates transcription in yeast. Nature 332, 649-650 (1988).
31. Lech, K., Anderson, K. & Brent, R. DNA-bound Fos proteins activate transcription in yeast. Cell 52, 179-184 (1988). References 30 and 31 show that mammalian activators can function in yeast.
32. McEwan, I. J. Bakers yeast rises to the challenge: reconstitution of mammalian steroid receptor signaling in S. cerevisiae. Trends Genet. 17, 239-243 (2001).
33. Metzger, D., White, J. H. & Chambon, P. The human oestrogen receptor functions in yeast. Nature 334, 31-36 (1988).
34. Schena, M. & Yamamoto, K. R. Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science 241, 965-967 (1988). References 33 and 34 were the first to show that nuclear steroid hormone receptors activate transcription in yeast.
35. Kunzler, M., Braus, G. H., Georgiev, O., Seipel, K. & Schaffner, W. Functional differences between mammalian transcription activation domains at the yeast GAL1 promoter. EMBO J. 13, 641-645 (1994).
36. Kim, T. K. & Roeder, R. G. Transcriptional activation in yeast by the proline-rich activation domain of human CTF1. J. Biol. Chem. 268, 20866-20869 (1993).
37. Ponticelli, A. S., Pardee, T. S. & Struhl, K. The glutamine-rich activation domains of human Sp1 do not stimulate transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 983-988 (1995).
38. Prakash, K., Fang, X. D., Engelberg, D., Behal, A. & Parker, C. S. dOct2, a Drosophila Oct transcription factor that functions in yeast. Proc. Natl Acad. Sci. USA 89, 7080-7084 (1992).
39. Xiao, H. & Jeang, K. T. Glutamine-rich domains activate transcription in yeast Saccharomyces cerevisiae. J. Biol. Chem. 273, 22873-22876 (1998).
40. Escher, D., Bodmer-Glavas, M., Barberis, S. & Schaffner, W. Conservation of glutamine-rich transactivation function between yeast and humans. Mol. Cell. Biol. 20, 2774-2782 (2000). Interesting study that shows that re-establishing a mammalian promoter structure in yeast might be important for a corresponding mammalian activator to function in yeast.
41. Giese, K., Cox, J. & Grosschedl, R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69, 185-195 (1992).
42. Paull, T. T., Haykinson, M. J. & Johnson, R. C. The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev 7, 1521-1534 (1992).
43. Landsman, D. & Bustin, M. Assessment of the transcriptional activation potential of the HMG chromosomal proteins. Mol. Cell. Biol. 11, 4483-4489 (1991).
44. Ma, J. & Ptashne, M. A new class of yeast transcriptional activators. Cell 51, 113-119 (1987).
45. Morin, P. J. & Gilmore, T. D. The C terminus of the NF-κB p50 precursor and an IκB isoform contain transcription activation domains. Nucleic Acids Res. 20, 2453-2458 (1992).
46. Pham, T. A., Hwung, Y.-P., Santiso-Mere, D., McDonnell, D. P. & O'Malley, B. W. Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol. Endocrinol. 6, 043-1050 (1992).
47. Chen, R. H. & Lipsick, J. S. Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 4423-4431 (1993).
48. Seneca, S. et al. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast. Oncogene 8, 2335-2342 (1993).
49. Xie, K., Lambie, E. J. & Snyder, M. Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol. 13, 6170-6179 (1993).
50. Monaci, P. et al. A complex interplay of positive and negative elements is responsible for the different transcriptional activity of liver NF1 variants. Mol. Biol. Rep. 21, 147-158 (1995).
51. Yamaguchi, Y. & Kuo, M. T. Functional analysis of aryl hydrocarbon receptor nuclear translocator interactions with aryl hydrocarbon receptor in the yeast two-hybrid system. Biochem. Pharmacol. 50, 1295-1302 (1995).
52. Monteiro, A. N. A., August, A. & Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl Acad. Sci. USA 93, 13595-13599 (1996).
53. Rowlands, J. C., McEwan, I. J. & Gustafsson, J.-Å. Transactivation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Mol. Pharmocol. 50, 538-548 (1996).
54. Hecht, A., Letterst, C. M., Huber, O. & Kemier, R. Functional characterization of multiple transactivating elements in β-catenin, some of which interact with the TATA-binding protein in vitro. J. Biol. Chem. 274, 18017-18025 (1999).
55. Almlöf, T., Gustafsson, J.-Å. & Wright, A. P. H. Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol. Cell. Biol. 17, 934-945 (1997).
56. Fields, S. & Jang, S. K. Presence of a potent transcription activating sequence in the p53 protein. Science 249, 1046-1049 (1990).
57. Shimada, A. et al. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. Cancer Res. 59, 2781-2789 (1999).
58. Nozaki, M. et al. p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade. Brain Pathol. 11, 296-305 (2001).
59. Scharer, E. & Iggo, R. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 20, 1539-1545 (1992). This paper shows that tumour-derived p53 mutants fail to activate transcription in yeast.
60. Di Como, C. J. & Prives, C. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene 16, 2527-2539 (1998).
61. Flaman, J. M. et al. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene 16, 1369-1372 (1998).
62. Campomenosi, P. et al. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene 20, 3573-3579 (2001).
63. Epstein, C. B. et al. p53 mutations isolated in yeast based on loss of transcription factor activity: similarities and differences from p53 mutations detected in human tumors. Oncogene 16, 2115-2122 (1998).
64. Ishioka, C. et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature Genet. 5, 124-129 (1993).
65. Meinhold-Heerlein, I. et al. Evaluation of methods to detect p53 mutations in ovarian cancer. Oncology 60, 176-188 (2001).
66. Inga, A. et al. Simple identification of dominant p53 mutants by a yeast functional assay. Carcinogenesis 18, 2019-2021 (1997).
67. Inga, A., Monti, P., Fronza, G., Darden, T. & Resnick, M. A. p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay. Oncogene 20, 501-513 (2001).
68. Brachmann, R. K., Yu, K., Eby, Y., Pavletich, N. P. & Boeke, J. D. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations. EMBO J. 17, 1847-1859 (1998). Isolation of second-site intragenic mutations which restore transactivation to tumour-derived TP53 mutants - a possible framework for small-molecule design.
69. Maurici, D. et al. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay. Oncogene 20, 3533-3540 (2001).
70. Nigro, J. M., Sikorski, R., Reed, S. I. & Vogelstein, B. Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol. Cell. Biol. 12, 1357-1365 (1992).
71. Inga, A. & Resnick, M. A. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants. Oncogene 20, 3409-3419 (2001).
72. Olson, D. P. & Koenig, R. J. 5′-flanking sequences in thyroid hormone response element half-sites determine the requirement of retinoid X receptor for receptor-mediated gene expression. J. Biol. Chem. 272, 9907-9914 (1997).
73. Brent, G. A. et al. Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element. Mol. Endocrinol. 3, 1996-2004 (1989).
74. Katz, R. W. & Koenig, R. J. Nonbiased identification of DNA sequences that bind thyroid hormone receptor α1 with high affinity. J. Biol. Chem. 268, 19392-19397 (1993).
75. Berge, T., Bergholtz, S. L., Andersson, K. B. & Gabrielson, O. S. A novel system for in vivo selection of recognition sequences: defining an optimal c-Myb-responsive element. Nucleic Acids Res. 29, E99 (2001). This report describes a system to identify optimal mammalian transcription-factor-binding sites in yeast.
76. Henry, K. W., Carey, B., Howard, W. R., Hoefner, D. & Noonan, D. J. Use of Saccharomyces cerevisiae in the identification of novel transcription factor DNA binding specificities. Yeast 18, 445-454 (2001).
77. Yoshinaga, S. K., Peterson, C. L. Herskowitz, I. & Yamamoto, K. R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258, 1598-1604 (1992). This study shows that glucocorticoid-receptor-dependent activation requires the SWI-SNF complex.
78. Cairns, B. R., Levinson, R. S., Yamamoto, K. R. & Komberg, R. D. Essential role of Swp73p in the function of yeast Swi/Snf complex. Genes Dev. 10, 2131-2144 (1996).
79. Gilbert, D. M., Losson, R. & Chambon, P. Ligand dependence of estrogen receptor induced changes in chromatin structure. Nucleic Acids Res. 20, 4525-4531 (1992).
80. Henrikksson, A. et al. Role for the Ada adaptor complex in gene activation by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3065-3073 (1997). This paper shows that glucocorticoid-receptor-dependent activation requires the SAGA-ADA complex.
81. Wallberg, A. E. et al. Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor τ1 activation domain. Mol. Cell. Biol. 20, 2004-2013 (2000).
82. Anafi, M. et al. GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. Mol. Endocrinol. 14, 718-732 (2000).
83. Vom Baur, E. et al. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. Genes Dev. 12, 1278-1289 (1998).
84. Bortvin, A. & Winston, F. Evidence that Spt6p controls chromatin structure by a direct interaction with histones. Science 272, 1473-1476 (1996).
85. Hartzog, G. A., Wada, T., Handa, H. & Winston, F. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12, 357-369 (1998).
86. Wada, T. et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343-356 (1998).
87. Baniahmad, C. et al. Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol. Endocrinol. 9, 34-43 (1995).
88. Knutti, D., Kaul, A. & Kralli, A. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol. Cell. Biol. 20, 2411-2422 (2000). The authors carry out a screen, which identifies PGC-1 as a complementary DNA that potentiates glucocorticoid-receptor function in yeast.
89. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
90. Puigserver, P. et al. Activation of PPARγ coactivator-1 through transcription factor docking. Science 286, 1368-1371 (1999).
91. Monsalve, M. et al. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol. Cell 6, 307-316 (2000).
92. Garabedian, M. J. & Yamamoto, K. R. Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Mol. Biol. Cell 3, 1245-1257 (1992). This report uses yeast to analyse the hormone-binding domain of the glucocorticoid receptor.
93. Wrenn, C. K. & Katzenellenbogan, B. S. Structure-function analysis of the hormone binding domain of the estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J. Biol. Chem. 268, 24089-24098 (1993).
94. Lind, U., Carlstedt-Duke, J., Gustafsson, J.-Å. & Wright A. P. H. Identification of single amino acid substitutions of Cys-736 that affect the steroid-binding affinity and specificity of the glucocorticoid receptor using phenotypic screening in yeast. Mol. Endocrinol. 10, 1358-1370 (1996).
95. Kralli, A., Bohen, S. P. & Yamamoto, K. R. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl Acad. Sci. USA 92, 4701-4705 (1995).
96. Gilbert, D. M., Heery, D. M., Losson, R., Chambon, P. & Lemoine, Y. Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1. Mol. Cell. Biol. 13, 462-472 (1993).
97. Sitcheran, R., Emter, R., Kralli, A. & Yamamoto, K. R. A genetic analysis of glucocorticoid receptor signaling: identification and characterization of ligand-effect modulators in Saccharomyces cerevisiae. Genetics 156, 963-972 (2000).
98. Housley, P. R. & Pratt, W. B. Direct demonstration of glucocorticoid receptor phosphorylation by intact L-cells. J. Biol. Chem. 258, 4630-4635 (1983).
99. Orti, E., Mendel, D. B., Smith, L. I. & Munck, A. Agonist dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells. J. Biol. Chem. 264, 9728-9731 (1989).
100. Hoeck, W. & Groner, B. Hormone-dependent phosphorylation of the glucocorticoid receptor occurs mainly in the amino-terminal transactivation domain. J. Biol. Chem. 265, 5403-5408 (1990).
101. Pocuca, N., Ruzdijic, S., Demonacos, C., Kanazir, D. & Krstic-Demonacos, M. Using yeast to study glucocorticoid receptor phosphorylation. J. Steroid Biochem. 66, 303-318 (1998).
102. Krstic, M. D., Rogatsky, I., Yamamoto, K. R. & Garabedian, M. J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3947-3954 (1997).
103. Epinat, J.-C., Whiteside, S. T., Rice, N. R. & Israel, A. Reconstitution of the NF-κB system in Saccharomyces cerevisiae for isolation of effectors by phenotype modulation. Yeast 13, 599-612 (1997).
104. Ayer, D. E., Kertzmer, L. & Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activily. Cell 72, 211-222 (1993).
105. Kasten, M. M., Ayer, D. E. & Stillman, D. J. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein. Mol. Cell. Biol. 16, 4215-4221 (1996). This, to my knowledge, is the first report showing that mammalian repressors function in yeast.
106. Ayer, D. E., Lawrence, O. A. & Eisenman, R. N. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776 (1995).
107. Weintraub, S. J., Prater, C. J. & Dean, D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259-261 (1992).
108. Laherty, C. D. et al. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89, 349-356 (1997).
109. Kennedy, B. K. et al. Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc. Natl Acad. Sci. USA 98, 8720-8725 (2001).
110. Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601 (1998).
111. Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473 (1998).
112. Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605 (1998).
113. Chen, T.-T. & Wang, J. Y. J. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell. Biol. 20, 5571-5580 (2000).
114. Dahiya, A., Gavin, M. R., Luo, R. X. & Dean, D. C. Role of the LXCXE binding site in Rb function. Mol. Cell. Biol. 20, 6799-6805 (2000).
115. Dick, F. A., Sailhamer, E. & Dyson, N. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 20, 3715-3727 (2000).